Zusammenfassung
Unter Demenz versteht man einen erworbenen Abbau kognitiver Fähigkeiten von einem höheren Ausgangsniveau, der zu einem Verlust von Alltagsfertigkeiten und in der Mehrheit der Fälle zu Verhaltensstörungen führt.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alladi, S., Xuereb, J., Bak, T., Nestor, P., Knibb, J., Patterson, K., Hodges, J.R. (2007). Focal cortical presentations of Alzheimer’s disease. Brain 130, 2636–2645.
Baker, M. Mackenzie, I.R., Pickering-Brown, S.M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A.D., Rollinson, S., Cannon, A., Dwosh, E., Neary, D., Melquist, S., Richardson, A., Dickson, D., Berger, Z., Eriksen, J., Robinson, T., Zehr, C., Dickey, C. A., Crook, R., McGowan, E., Mann, D., Boeve, B., Feldman, H., Hutton, M. (2006). Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916–919.
Blennow, K. (2006). Alzheimer’s disease. Lancet 368, 387–403.
Dubois B. Feldman, H.H., Jacova, C., Dekosky, S.T., Barberger-Gateau, P. Cummings, J., Delacourte, A., Galasko, D., Gautheir, S., Jicha, G., Meguro, K., O’brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Stern, Y., Visser, P.J., Scheltens, P. (2007). Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734–746.
Emre, M. Aarsland, D., Brown, R., Burn, D.J., Duyckaerts, C., Mizuno, Y., Broe, G.A., Cummings, J., Dickson, D.W., Gauthier, S., Goldman, J., Goetz, C., Korczyn, A., Lees, A., Levy, R., Litvan, I., McKeith, I., Olanow, W., Poewe, W., Quinn, N., Sampaio, C., Tolosa, E., Dubois, B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorder 22, 1689–1707.
Grimmer, T. et al (2008). Aktueller Stand der Immuntherapie bei Alzheimer-Krankheit. Nervenarzt 79, 832–835.
Hamann, G. F., Perneczky, R., Kurz, A. (2005). Vaskuläre Demenzen. In Diener, H. C. et al. (Hg.) Leitlinien für Diagnostik und Therapie in der Neurologie (e. überarb. Aufl.). Stuttgart: Thieme, S. 284–290.
Josephs, A. et al. (2008). Frontotemporal dementia and related disorders: Deciphering the enigma. Annals of Neurology 64, 4–14.
Kavirajan, H., Schneider, L.S. (2007). Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. The Lancet Neurology 6, 782–792.
Loeb, C., Meyer J. S. (1996). Vascular dementia: still a debatable entity? Journal of the Neurological Sciences 143, 31–40.
Mallucci, G., Collinge, J. (2004). Update on Creutzfeldt-Jakob disease. Current Opinion in Neurology 17, 641–647.
McKeith, I.G. Dickson, D.W., Lowe, J., Emre, M., O’Brien, J.T., Feldman, H., Cummings, J., Ducla, J.E., Lippa, C., Perry, E.K., Aarsland, D., Arai, H., Ballard, C.G., Boeve, B., Burn, D.J., Costa, D., Del Ser, T., Dubois, B., Galasko, D., Gauthier, S., Goetz, C.G., Gomez-Tortosa, E., Halliday, G., Hansen, L.A., Hardy, J., Iwatsubo, T., Kalaria, R.N., Kaufer, D., Kenny, R.A., Korczyn, A., Kosaka, K., Lee, V.M., Lees, A., Litvan, I., Londos, E., Lopez, O.L., Minoshima, S., Mizuno, Y., Molina, J.A., Mukaetova-Ladinska, E.B., Pasquier, F., Perry R.H., Schulz, J.B., Trojanowski, J.Q., Yamada, M.; (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 1863–1872.
McKhann, G., Drachman, D., Folstein, M. Katzman R., Price, D., Stadlan, EM. (1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34, 939–944.
Moorhouse, P., Rockwood, K. (2008). Vascular cognitive impairment: current concepts and clinical Developments. The Lancet Neurology 7, 246–255.
Neary, D. (2005). Frontotemporal dementia. The Lancet Neurology 4, 771–780.
Petersen, R.C., Stevens, J.C., Ganguli, M., Tangalos, E.G., Cummings, J.L., DeKosky, S.T. (2001). Practice parameter: early detection of dementia: mild cognitive impairment (an evidence based review). Neurology 96, 1133–1142.
Ratnavalli, E., Brayne, C., Dawson, K., Hodges, J.R. (2002). The prevalence of frontotemporal dementia. Neurology 58, 1615–1621.
Rockwood, K.I., Parhad, I., Hachinski, V., Erkinjuntti, T., Rewcastle, B., Kertesz, A., Eastwood, M.R., Phillips, S. (1994). Diagnosis of vascular dementia: consortium of Canadian centers for clinical cognitive research consensus statement. Canadian Journal of Neurological Sciences 21, 358–336.
Seelaar, H., Kamphorst, W., Rosso, S.M., Azmani, A., Masdjedi, R., de Koning, I., Maat-Kievit, J.A., Anar, B., Kaat, L.D., Breedveld, G.J., Dooijes, D., Rozemuller, J.M., Bronner, I.F., Rizzu, P., van Swieten, J.C. (2008). Distinct genetic forms of frontotemporal dementia. Neurology 14, 71, 1220–1226.
Sorrentino, G., Migliaccio, R., Bonavita, V. (2008). Treatment of vascular dementia: the route of prevention. European Neurology 60, 217–223.
Stevens, T., Livingston, G., Kitchen, G., Manela, M., Walker, Z., Katona, C. (2002). Islington study of dementia subtypes in the community. British Journal of Psychiatry 180, 270–276.
Vellas, B., Andrieu, S., Sampaio, C., Wilcock, G.; (2007). Disease-modifying trials in Alzheimer’s disease: a European task force consensus. The Lancet Neurology 6, 56–62.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Assem-Hilger, E., Pirker, W. (2010). Klinik der Demenzen. In: Gedächtnistraining. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01067-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-01067-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01066-8
Online ISBN: 978-3-642-01067-5
eBook Packages: Humanities, Social Science (German Language)